Vivici, a Leiden, the Netherlands-based ingredients startup providing Vivitein™, its proprietary protein platform, raised €32.5M in Series A funding.
The round was led by APG on behalf of ABP, and Invest-NL, with participation from InnovationQuarter and existing shareholders dsm-firmenich and Fonterra.
The company intends to use the funds to expand its access into new international markets, launch its second dairy protein ingredient, and establish long-term manufacturing capabilities.
Founded in 2023 and led by CEO Stephan van Sint Fiet, Vivici, through its precision fermentation method to create dairy protein, combines the process of traditional fermentation with the latest advances in biotechnology, producing proteins without the need for animals. The technology promises to sustainably meet the protein needs of the world’s growing population, without compromising on price, taste, or nutritional quality.
FinSMEs
25/02/2025